Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Return on Equity (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Return on Equity for 12 consecutive years, with 1.01% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 281.0% year-over-year to 1.01%, compared with a TTM value of 1.01% through Dec 2025, up 281.0%, and an annual FY2025 reading of 0.91%, up 257.0% over the prior year.
  • Return on Equity was 1.01% for Q4 2025 at Neuroone Medical Technologies, down from 0.47% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.47% in Q3 2025 and bottomed at 6.43% in Q3 2024.
  • Average Return on Equity over 5 years is 1.93%, with a median of 1.22% recorded in 2021.
  • The sharpest move saw Return on Equity crashed -409bps in 2024, then soared 595bps in 2025.
  • Year by year, Return on Equity stood at 0.96% in 2021, then decreased by -5bps to 1.0% in 2022, then tumbled by -152bps to 2.53% in 2023, then crashed by -51bps to 3.83% in 2024, then surged by 74bps to 1.01% in 2025.
  • Business Quant data shows Return on Equity for NMTC at 1.01% in Q4 2025, 0.47% in Q3 2025, and 1.15% in Q2 2025.